Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Heuzé-Vourc'h (Tours, France). Understanding the behaviours of inhaled biologicals at the airway epithelium. International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments

Member's Comments

No comment yet.

Related content which might interest you: Assessing regional airways responses to inhaled bronchodilators in asthmatics Source: Annual Congress 2010 - Airways mechanics in different applications Year: 2010 Comparative airway response to high- versus low-molecular weight agents in occupational asthma Source: Eur Respir J 2009; 33: 734-739 Year: 2009 Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics Source: Eur Respir J, 56 (5) 2000260; 10.1183/13993003.00260-2020 Year: 2020 Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma Source: Eur Respir J 2006; 27: 172-187 Year: 2006 Influence of inhaled corticosteroids on airway epithelial cell mediator release in wheezing children Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Tobacco smoking alters the relationship between airway inflammation and airway hyperresponsiveness in asthma Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease Year: 2012 Effect of montelukast on excessive airway narrowing in adult asthmatics not on controller therapy Source: Annual Congress 2006 - New developments in the treatment and management of asthma Year: 2006 Understanding the mechanisms of LASSBio596 on airway remodeling in asthma Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment Year: 2007 In vivo evaluation of the airway epithelium in a murine model of allergic asthma: effects of bronchodilators on ciliary beat frequency Source: Eur Respir J 2006; 28: Suppl. 50, 219s Year: 2006 B2-adrenoceptor genotype16 influences airway calibre but not hyperresponsiveness in asthmatics using regular B2-agonist in addition to inhaled corticosteroids Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Mycobiota of the pharynx in patients with persistent bronchial asthma who constantly applying the inhaled corticosteroids Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Anti-IL-5 therapy and the airway microbiome in asthma. Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020 Metabolic differences in bronchial epithelium from asthma patients and impact of bronchial thermoplasty Source: Virtual Congress 2020 – Metabolic alterations and ageing in lung disease Year: 2020 Influence of endogenous corticosteroids on bronchial protective properties of β2-agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 Novel concepts in airway inflammation and remodelling in asthma Source: Eur Respir J 2015; 46: 1796-1804 Year: 2015 Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 Molecular-cellular mechanisms of combined airway hyperresponsiveness in asthma Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Effects of active and passive smoking on allergic airway inflammation and airway hyperresponsiveness in mice Source: Eur Respir J 2002; 20: Suppl. 38, 310s Year: 2002 Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: Eur Respir J 2017; 49(1): 1600839; DOI: 10.1183/13993003.00839-2016 Year: 2017